Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has announced the application for the quotation of new securities on the Australian Securities Exchange (ASX). The announcement involves the issuance of 77 ordinary fully paid securities under an employee incentive scheme, which are set to be quoted on October 29, 2025. This move is part of Cochlear’s ongoing efforts to incentivize its workforce and align employee interests with company performance, potentially strengthening its market position and stakeholder relations.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$320.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, primarily focusing on the development and manufacturing of implantable hearing solutions. The company is known for its cochlear implants and other hearing-related products, serving a global market with a focus on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 135,782
Technical Sentiment Signal: Buy
Current Market Cap: A$18.98B
Learn more about COH stock on TipRanks’ Stock Analysis page.